Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Ananda Pharma PLC 03 February 2025 3 February 2025 ANANDA PHARMA PLC ("Ananda" or the "Company") Change of Registered Office Ananda (AQSE: ANA), a Company focused on the development of...
Ananda Pharma PLC 03 February 2025 03 February 2025 ANANDA PHARMA PLC ("Ananda" or the "Company") Ananda Pharma Appoints Viridian Capital Advisors to Advance U.S. Market Strategy...
Ananda Pharma PLC 07 January 2025 07 January 2025 Ananda Pharma plc ("Ananda" or the "Company") Total Voting Rights In accordance with the Financial Conduct Authority's Disclosure...
Ananda Developments PLC 20 December 2024 20 DECEMBER 2024 ANANDA PHARMA PLC (formerly ANANDA DEVELOPMENTS PLC) ("Ananda" or the "Company") Change of Name Ananda (AQSE: ANA), a...
Ananda Developments PLC 11 December 2024 11 December 2024 ANANDA DEVELOPMENTS PLC ("Ananda" or the "Company") Subscription to raise £150,000 Ananda Developments plc (AQSE: ANA), a...
Ananda Developments PLC 09 December 2024 9th December 2024 ANANDA DEVELOPMENTS PLC ("Ananda" or the "Company") Further Promising Results for MRX1 treating Heart Failure Ananda...
Ananda Developments PLC 03 December 2024 3rd December 2024 ANANDA DEVELOPMENTS PLC ("Ananda" or the "Company") Key Stability Testing Milestones Achieved for MRX1 Ananda Developments...
Ananda Developments PLC 12 November 2024 12 November 2024 ANANDA DEVELOPMENTS PLC ("Ananda" or the "Company") Director Dealing Ananda Developments plc (AQSE: ANA) announces that...
Ananda Developments PLC 31 October 2024 31 October 2024 Ananda Developments plc ("Ananda Developments" or the "Company") Total Voting Rights In accordance with the Financial Conduct...
ts PLC - London-based life sciences company focused on the development of cannabinoid-based therapies for complex infl ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.01 | 2.29885057471 | 0.435 | 0.457 | 0.42 | 1072342 | 0.43974709 | DE |
| 4 | -0.065 | -12.7450980392 | 0.51 | 0.525 | 0.4 | 1522227 | 0.43933606 | DE |
| 12 | 0.125 | 39.0625 | 0.32 | 26.21 | 0.3 | 1470616 | 0.42356907 | DE |
| 26 | -0.055 | -11 | 0.5 | 26.21 | 0.25 | 1180267 | 0.3982463 | DE |
| 52 | 0.12 | 36.9230769231 | 0.325 | 26.21 | 0.175 | 1030624 | 0.39268794 | DE |
| 156 | -0.445 | -50 | 0.89 | 26.21 | 0.175 | 833558 | 0.45676142 | DE |
| 260 | 0.235 | 111.904761905 | 0.21 | 26.21 | 0.07 | 979942 | 0.66831821 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
